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ABSTRACT
Objective: Multimorbidity affects 26 million persons
with diabetes, and care for comorbid chronic
conditions may impact diabetes care quality. The aim
of this study was to determine which chronic
conditions were related to lack of achievement or
achievement of diabetes care quality goals to determine
potential targets for future interventions.
Research design and methods: This is an
exploratory retrospective analysis of electronic health
record data for 23 430 adults, aged 18–75, with
diabetes who were seen at seven Midwestern US health
systems. The main outcome measures were
achievement of six diabetes quality metrics in the
reporting year, 2011 (glycated haemoglobin (HbA1c)
control and testing, low-density lipoprotein control and
testing, blood pressure control, kidney testing).
Explanatory variables were 62 chronic condition
indicators. Analyses were adjusted for baseline patient
sociodemographic and healthcare utilization factors.
Results: The 62 chronic conditions varied in their
relationships to diabetes care goal achievement for
specific care goals. Congestive heart failure was related
to lack of achievement of cholesterol management
goals. Obesity was related to lack of HbA1c and BP
control. Mental health conditions were related to both
lack of achievement and achievement of different care
goals. Three conditions were related to lack of
cholesterol testing, including congestive heart failure
and substance-use disorders. Of 17 conditions related
to achieving control goals, 16 were related to achieving
HbA1c control. One-half of the comorbid conditions
did not predict diabetes care quality.
Conclusions: Future interventions could target
patients at risk for not achieving diabetes care for
specific care goals based on their individual
comorbidities.
The vast majority, over 83%, of patients with
diabetes in the USA, has at least one other
co-occurring chronic condition, and diabetes
care quality remains suboptimal with stagger-
ing levels of morbidity and mortality.1 2
Multimorbidity adds additional care
demands to the already complex diabetes
care. The US Department of Health and
Human Services, The Institute of Medicine,
the Patient-Centered Outcome Research
Institute and others have recognized the
need to understand and improve multimor-
bidity care.3–6 Unfortunately, there are few
current multimorbidity interventions to
improve diabetes care, as demonstrated by a
recent Cochrane review.7 One reason for the
limited number of interventions may be that
the relationship of individual comorbid
chronic conditions to elements of diabetes
care is not known.3 Only a few specific
conditions, such as hypertension and depres-
sion,8–10 have been assessed for their individ-
ual impact on diabetes care and even then
for a limited set of care goals. As diabetes
care quality consists of achieving multiple
care goals, including both testing and
control goals, individual conditions could
have a different relationship with diabetes
care for each care goal. Without knowing
these relationships, we cannot identify
patients at risk for not achieving care goals
Future research questions
▪ Do these relationships hold up in other
populations?
▪ How do individual conditions and combinations
of individual conditions relate to other outcomes
in patients with diabetes?
▪ How can we best improve care for patients with
diabetes and select comorbid conditions?
Key messages
▪ Individual conditions have unique relationships
with diabetes care goal achievement.
▪ Congestive heart failure was associated with lack
of achievement of both low-density lipoprotein
control and testing goals.
▪ Individual mental health conditions were asso-
ciated with not achieving certain care goals, and
achieving other care goals.
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based on their comorbidities, and we cannot target
interventions to improve care for specific diabetes care
goals in patients with the selected comorbidities.
A conceptual model suggests that the relationship
between comorbid conditions and diabetes care is due
to characteristics of the comorbid condition.11 In this
framework, patients with conditions that share care goals
with diabetes (concordant) are more likely to achieve
diabetes care goals, while patients with conditions that
do not share care (discordant) are less likely to achieve
diabetes care goals. In addition, care for severe and/or
symptomatic conditions would preferentially be priori-
tized over care for diabetes. Past studies on the impact
of chronic conditions on diabetes management have
considered only one condition characteristic (eg, con-
cordant/discordant or severe/not severe) and consid-
ered all conditions classified as the same type (eg,
discordant) as equivalent when determining impact on
diabetes care.11–16 However, in actuality, some conditions
might have a greater or lesser impact on diabetes testing
and control goal achievement than other conditions.
For example, a diagnosis of cancer might have a greater
impact on diabetes management than heartburn. It is
most likely that the overall impact of a chronic condition
on diabetes care is due to a combination of its many
characteristics (concordant/discordant, severity,
symptom level) as well as other factors such as treatment
needs and pathophysiology. Therefore, it is important to
consider the impact of individual conditions, not just
classes of conditions based on their characteristics.
The objective of this study was to determine the rela-
tionship between individual chronic conditions and the
achievement of publicly-reported diabetes quality care
goals in patients with diabetes. We did this at the individ-
ual condition level to study the combined impact of all
potential condition characteristics. We hypothesized that
the relationship between the condition and the achieve-
ment of diabetes care goals would vary for each condi-
tion and care goal, with achievement of that goal
(positive association with achievement), lack of achieve-
ment of that goal (negative association with achieve-
ment), or no relationship with care (no association).
RESEARCH DESIGN AND METHODS
Design and setting
We conducted a retrospective analysis of 2 years of elec-
tronic health data, 2010 (baseline year) and 2011
(quality reporting year), for seven health systems that
participated in a Midwestern quality reporting collabora-
tive, the Wisconsin Collaborative for Healthcare Quality.
The health systems are academic and community prac-
tices in rural, suburban and urban settings, and all
submit data electronically for public reporting using
standardized methodology.17 The Minimal Risk Health
Sciences Institutional Review Board at the University of
Wisconsin determined that the project was exempt from
oversight.
Patients
All patients with a diagnosis of diabetes (type 1 or type 2),
who were 18–75 years old, and were medically homed
within the seven participating health systems were
included in the sample.17 We focused on patients eligible
for public reporting of diabetes quality care metrics to
ensure general consensus about the definition of diabetes
quality care goals. Diabetes was defined by at least two
face-to-face ambulatory visits (using CPT-4 outpatient
evaluation and management codes) with any clinician
with an International Classification of Diseases Ninth
Edition (ICD-9) diagnosis code of 250.XX, 357.2, 362.0X,
366.41 or 648.0X on different dates of service over the
2 years of data.17 Medically homed was defined as at least
two face-to-face office visits to the group on different dates
of service in the past 2 years, with at least one visit in the
reporting year.17
Primary outcome variables
Our primary outcome variables were the achievement of
three control and three testing diabetes care goals,
recommended in clinical guidelines, used in public
reporting, measurable in a standardized fashion across
populations and health systems and shown to be asso-
ciated with macrovascular and microvascular outcomes
in diabetes.17 18 Variables were binary, representing care
goal achievement or not in the reporting year, as
defined by the public reporting collaborative that
reports on the participating health systems. The three
control goals were: HbA1c control <7% (or <8% if
65–75 years old or having specific comorbidities);17–19
LDL cholesterol control <100 mg/dL; blood pressure
(BP) control at <130/80 mm Hg. The specific comorbid-
ities were: coronary artery bypass graft, percutaneous
transluminal coronary angioplasty, ischemic vascular
disease, congestive heart failure, myocardial infarction,
chronic renal failure, dementia, blindness and amputa-
tion (lower extremity).17
The three testing goals measured in the reporting
year were as follows: HbA1c testing two or more times;
LDL cholesterol testing; kidney function testing by
either a urine microalbumin test or documented evi-
dence of nephropathy.17 18 Documented evidence of
nephropathy, as defined by the public reporting collab-
orative that reports on the participating health systems,
included a visit to a nephrologist for any reason, a diag-
nosis code for chronic kidney disease or renal manifesta-
tions of diabetes or evidence of dialysis treatment during
the reporting year.17
Main explanatory variables
Indicator variables for patient comorbidities were the
main explanatory variables. We used a comprehensive
set of 62 chronic condition indicators (excluding dia-
betes) based on an established list of outpatient-relevant
chronic conditions developed from the AHRQ Clinical
Classification Software (CCS) categories for medical con-
ditions.20 21 The 62 chronic condition indicators cover
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1412 ICD-9 codes, with several codes for similar or the
same condition(s) counted as the presence of one con-
dition (eg, multiple codes for types of coronary artery
disease are counted as the patient having a coronary
artery disease). Chronic conditions were defined as
ICD-9 codes billed at one or more face-to-face visits in
the baseline year. This was carried out to ensure that the
conditions were present and actively managed in the
clinic before the quality reporting time frame. See
online supplementary appendix table 1 for a list of the
62 conditions organized by body system.
Covariates
We defined variables for patient sociodemographic
characteristics and healthcare utilization. Sociodemographic
characteristics were age (continuous), gender, race (white
or other) and insurance (non-commercial Medicare,
Medicaid, commercial (including commercial Medicare)
or self-pay/unreported). We defined two additional socio-
economic status proxy variables by linking patient zip
codes to census tract data. These are the per cent of the
population in the patient’s zip code who live below the
poverty line and the per cent who do not have a high
school education. Healthcare utilization was defined as
number of face-to-face office visits in the baseline year
(coded as 4 categories).17 22 We also included an indicator
for health system to account for clustering. To account for
potential contextual effects, we developed a variable for
the prevalence of self-reported diabetes in each patient’s
county of residence, and a variable for the per cent of all
Medicare patients in the county who have had HbA1c
testing, from patient zip codes linked to the University of
Wisconsin Population Health Institute-Robert Wood
Johnson County Health Rankings.23 We also determined
rural–urban commuting area codes based on each
patient’s zip code (RUCA, 4 level).24
Statistical analyses
All analyses were conducted using Stata V.13.0 (Stata-
Corp, College Station, Texas, USA). There were no
missing data for any covariates or outcome variables.
Outcome variables were coded as testing or control
thresholds being met when in the health record, and
not being met when not recorded, as is the standard for
public reporting. Descriptive analyses summarized cat-
egorical variables using percentages and continuous
variables using means with SDs. Logistic regression
models were fit for each of the six diabetes control and
testing goals, to assess the relationship between 58 indi-
vidual chronic conditions and the achievement of each
care goal, adjusted for covariates as described above. All
conditions with more than 20 patients and all covariates
were used in all models to include all potentially rele-
vant variables. Four conditions with fewer than 20 condi-
tions (<0.1% prevalence) were not included in the
model: cystic fibrosis, tuberculosis, sickle cell anemia
and amyloidosis. Results are reported as OR and 95%
CIs. The significance of each condition on diabetes goal
achievement was determined at p value<0.01. These con-
servative significance values were used for this explora-
tory study to account for multiple comparisons, while
avoiding unnecessary increases in type 2 error that can
occur with Bonferroni correction. All conditions with
significant associations (p value<0.01) were present in at
least 93 patients.
RESULTS
Patient characteristics
Our sample had 23 430 patients with diabetes, between
the ages of 18 and 75 (table 1). Patients had 0–22
comorbid conditions, with an average of 3.8 (SD=2.5)
and a median of 3. The frequencies of all 62 chronic
conditions ranged from 77% for hyperlipidemia to
0.01% for tuberculosis (see online supplementary
appendix table 1).
Relationship of individual chronic conditions to diabetes
control
After controlling for patient sociodemographic factors
and number of office visits, nine conditions predicted
lack of achievement of specific control goals (table 2).
Of these conditions, five were related to not achieving
HbA1c control, including obesity and depression. Eight
conditions were related to lack of achievement of cardio-
vascular risk reduction goals (LDL and/or BP control).
These included: congestive heart failure (CHF), hyper-
tension, obesity, anxiety and substance abuse.
Seventeen conditions were related to achieving
control goals, and 15 to HbA1c control. Among these
were schizophrenia and bipolar disorder. Blood pressure
control was achieved with four conditions, including
obesity and substance use disorders.
Relationship of individual chronic conditions to
diabetes testing
All conditions that were related to lack of achievement
of testing goals were related to LDL testing (table 3).
These included: CHF and substance use disorders.
Obesity was among six conditions related to achieving
the HbA1c testing goal. Renal failure was strongly asso-
ciated with achieving kidney testing with an OR of 29.1
(95% CI 18.6 to 45.4); a diagnosis of renal failure meets
the kidney testing metric by definition.
Conditions with no relationship to diabetes control
or testing
Of 62 conditions, 33 were related to neither control nor
testing care goal achievement at p value <0.01, 4 add-
itional conditions were not related to control but were
related to testing, and 17 were not related to testing but
were related to control (table 4). These conditions span
multiple organ systems including cardiovascular and
mental health conditions, and many are low prevalence.
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DISCUSSION
We found that, as expected, the 62 chronic conditions
varied in their relationships to diabetes care goal
achievement for specific care goals. Several of the results
are especially pertinent to diabetes care and the devel-
opment of future interventions for care in multimorbid-
ity. CHF, obesity, and mental health disorders were all
related to lack of achievement for specific goals. HbA1c
control was achieved across multiple conditions, and for
many more conditions than LDL or BP control. Lack of
achievement of a testing goal was only seen with LDL
testing, with three individual conditions. Finally, half of
the comorbid conditions had no relationship to any of
the six diabetes care goals. Future interventions can
target selectively patients with specific comorbidities that
are associated with lack of achievement of diabetes care
goals.
CHF was related to lack of achievement of both LDL
control and testing. This was surprising as LDL manage-
ment is integral in CHF care, and based on the concep-
tual model of shared care leading to better diabetes
care, we expected CHF to be associated with achieving
LDL management goals.11 25 CHF showed no significant
association with BP control or HbA1c testing or control.
The reason that patients with CHF appear less likely to
achieve LDL control, but not less likely to achieve BP
control, an important goal in CHF,25 or HbA1c control,
could be due in part to patient priorities as a past study
that showed that cholesterol control was a lower priority
than BP or HbA1c control to patients with diabetes.26
Obesity was related to lack of achievement of HbA1c
and BP control, but achievement of the HbA1c testing
goals. The lack of control could be due to glucose and
BP dysregulation in obesity, or lifestyle factors that
worsen weight, HbA1c, and BP control. The lack of
HbA1c control despite guideline-adequate testing high-
lights the relative difficulty of achieving control com-
pared to completing a non-fasting laboratory test.
Control requires counseling at a visit and between-visit
self-care for a guideline-recommended 2 h/day,27 while
ordering a laboratory test and completing it at the visit,
requires relatively minimal effort from the provider and
patient.
Interestingly, while three mental health conditions
were associated with not achieving diabetes care for spe-
cific care goals, this was not for the same goals, and not
all mental health conditions were related to lack of care
goal achievement. Mental health conditions can present
barriers to diabetes care through lack of motivation or
an ability to perform self-care.8 28 Patients who do not
take prescribed medications or follow lifestyle recom-
mendations are less likely to achieve diabetes care goals.
Although we found associations with lack of care goals
achievement for patients with depression, substance
Table 1 Patient characteristics for total sample of patients with diabetes aged 18–76
Total sample (n=23 430)
Comorbidities
None (diabetes only, no other chronic conditions), % 7.7
Number of total comorbid conditions, mean (SD) 3.8 (2.5)
Number of concordant comorbid conditions, mean (SD) 2.2 (1.3)
Number of discordant comorbid conditions, mean (SD) 1.7 (1.7)
Age, mean (SD) 57.6 (1.7)
Sex, female, % 48
Race/ethnicity, white, % 70
Insurance, %
Commercial 50
Medicare 33
Medicaid 6
Uninsured/unreported, % 12
Number of visits in baseline year
<2 27
3 to 10 58
11 to 29 15
30 or more 1
RUCA, by patient’s zip code, %
Urban core 52
Suburban 16
Large own 9
Small town and rural 23
Per cent with diabetes in patient’s county, mean (SD) 8 (1)
Per cent with diabetes in patient’s county who achieved HbA1c testing, mean (SD) 89 (2.9)
Per cent below poverty line in patient’s zip code, mean (SD) 12 (8.7)
Per cent without HS education in patient’s zip code, mean (SD) 10 (5.6)
%, percentage; HbA1c, glycated haemoglobin.
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Table 2 Impact of individual concordant and discordant conditions on diabetes control goal achievement, adjusted, OR (95% CI), with prevalence of conditions, among
patients with diabetes age 18–75
Prevalence %
(n=23 430)
HgbA1c control LDL control BP control
OR (95% CI) p Value OR (95% CI) p Value OR (95% CI) p Value
Lack of control goal achievement
Obesity 22 0.9 (0.8 to 0.97) 0.0060 0.9 (0.85 to 0.97) 0.0050
Depression 15 0.9 (0.8 to 0.9) 0.0010
Anxiety disorders 8.0 0.8 (0.8 to 0.9) 0.0010
CNS/PNS disorders* 7.8 0.8 (0.7 to 0.9) 0.0000
Congestive heart failure 5.0 0.8 (0.7 to 0.9) 0.0060
Skin ulcer 4.8 0.8 (0.7 to 0.9) 0.0010
Degenerative eye problem 4.3 0.7 (0.6 to 0.8) 0.0000
Substance use disorders 0.8 0.6 (0.43 to 0.8) 0.0010
Mixed lack of achievement and achievement
Hypertension 74 1.1 (1.04 to 1.2) 0.0030 1.2 (1.1 to 1.3) 0.0000 0.6 (0.55 to 0.6) 0.0000
Control goal achievement
Hyperlipidemia 77 1.1 (1.1 to 1.2) 0.0000 1.3 (1.2 to 1.3) 0.0000 1.3 (1.17 to 1.3) 0.0000
Osteoarthritis 16 1.2 (1.1 to 1.3) 0.0000
Coronary atherosclerosis 14 1.3 (1.2 to 1.4) 0.0000 1.5 (1.4 to 1.6) 0.0000 1.3 (1.21 to 1.4) 0.0000
Allergic rhinitis 11 1.2 (1.1 to 1.3) 0.0000
Cancer 7.6 1.3 (1.1 to 1.4) 0.0000
Cardiac dysrhythmia 7.3 1.2 (1.05 to 1.3) 0.0040
Kidney and vesicoureteral disorders† 4.8 1.2 (1.05 to 1.4) 0.0090
Gout or other crystal arthropathy 4.4 1.2 (1.1 to 1.4) 0.0050
Benign prostatic hypertrophy 4.1 1.3 (1.1 to 1.6) 0.0010 1.2 (1.05 to 1.4) 0.0090
Bipolar disorder 3.7 1.2 (1.1 to 1.4) 0.0090
Rheumatoid arthritis 1.5 1.6 (1.3 to 2.1) 0.0000
Schizophrenia and psychotic disorders 1.1 1.7 (1.2 to 2.2) 0.0010
Aneurysm 0.7 1.9 (1.2 to 3) 0.0060
Epilepsy 0.7 2.1 (1.4 to 3.1) 0.0000
Myocardial infarction§ 0.5 2.0 (1.2 to 3.2) 0.0080
Parkinson’s disease 0.4 2.8 (1.4 to 5.4) 0.0020 2.4 (1.47 to 3.9) 0.0000
Adjusted for age, sex, race, insurance, number of face-to-face office visits in the baseline year, patient rural–urban commuting area, per cent with diabetes in patient’s county, per cent of
Medicare patients with diabetes in patient’s county who achieved HbA1c testing, per cent below poverty line in patient’s zip code, per cent without high school education in patient’s zip code,
health system.
All 62 conditions were included in the model. Only conditions with significant associations at p value<0.01 are listed in the table. All conditions are mutually exclusive.
*Excludes malignancies, multiple sclerosis and epilepsy.
†Excludes kidney failure.
§Within past 2 years.
CNS/PNS, central nervous system and peripheral nervous system; HbA1c, glycated haemoglobin.
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Table 3 Impact of individual concordant and discordant conditions on diabetes testing goal achievement, adjusted, OR (95% CI), with prevalence of conditions, among
patients with diabetes age 18–75
Diabetes care goal achieved
Prevalence %
(n=23 430)
HbA1c testing LDL testing Kidney testing
OR (95% CI) p Value OR (95% CI) p Value OR (95% CI) p Value
Lack of testing goal achievement
Congestive heart failure 5.0 0.6 (0.5 to 0.8) 0.0000
Substance use disorders 0.8 0.6 (0.4 to 0.8) 0.0010
Anemia 0.4 0.4 (0.2 to 0.7) 0.0020
Testing goal achievement
Hyperlipidemia 77 1.4 (1.3 to 1.5) 0.0000 2.9 (2.7 to 3.2) 0.0000 1.4 (1.3 to 1.5) 0.0000
Hypertension 74 1.1 (1.03 to 1.2) 0.0060
Obesity 22 1.2 (1.1 to 1.3) 0.0000
Thyroid disorder 15 1.2 (1.1 to 1.3) 0.0010
Coronary atherosclerosis 14 1.3 (1.1 to 1.5) 0.0010
Renal failure 11 1.3 (1.2 to 1.5) 0.0000 29.1 (18.6 to 45.4) 0.0000
CNS/PNS disorders* 7.8 1.2 (1.1 to 1.4) 0.0060
Kidney and vesicoureteral disorders† 4.8 2 (1.5 to 2.7) 0.0000
Menopause and perimenopause 3.6 1.5 (1.1 to 1.9) 0.0030
Bold represents conditions associated with lack of goal achievement.
Adjusted for age, sex, race, insurance, number of face-to-face office visits in the baseline year, patient rural–urban commuting area, per cent with diabetes in patient’s county, per cent of
Medicare patients with diabetes in patient’s county who achieved HbA1c testing, per cent below poverty line in patient’s zip code, per cent without high school education in patient’s zip code,
health system.
All 62 conditions were included in the model. Only conditions with significant associations at p value<0.01 are listed in the table. All conditions are mutually exclusive.
*Excludes malignancies, multiple sclerosis and epilepsy.
‡Excludes kidney failure.
CNS/PNS, central nervous system and peripheral nervous system; HbA1c, glycated haemoglobin.
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abuse and anxiety, we also found care goals achievement
with schizophrenia and bipolar disorder. Previous
studies on major mental health disorders in diabetes
showed better HbA1c control among those with schizo-
phrenia than those without major mental health condi-
tions.29 This could be due to increased provider
attention on these perceived high-risk patients. Our
results suggest that mental health barriers to diabetes
care vary by both condition and care goal, and are more
complicated than a simple negative association with any
care for all mental health conditions.
Notably, the vast majority of conditions that were
related to achieving at least one control goal were
related to achieving HbA1c control (15 of 17), while
only seven conditions were related to achieving cardio-
vascular control goals (LDL and BP). This is a matter of
concern as evidence shows that cardiovascular risk
reduction is more likely to reduce mortality in diabetes
than glycemic control.30 31 Several of the conditions that
were related to achieving HbA1c control, but not cardio-
vascular risk reduction, are not traditionally considered
diabetes-related (eg, allergic rhinitis, cancer) and should
Table 4 Individual chronic conditions with no significant effect on diabetes control or testing goal achievement
Both control and testing goal achievement Control goal achievement only Testing goal achievement only
Cardiac, vascular and pulmonary Genitourinary and reproductive Cardiac, vascular and pulmonary
COPD or asthma Renal failure Cardiac dysrhythmia
Stroke and TIA Menopause/perimenopause Aneurysm
Peripheral atherosclerosis Myocardial infarction
Vascular disease* Allergy and immunity
Cardiomyopathy Immunity disorder Muscoskeletal
Heart valve disorder Endocrine Osteoarthritis
Pulmonary heart disease Thyroid disorder Gout
Congenital heart disease Mental health
Thrombosis and embolism Depression
Muscoskeletal Anxiety disorders
Back problem Bipolar disorder
Mental health Schizophrenia
Behavior disorders Genitourinary and reproductive
Personality disorder Benign prostatic hypertrophy
Sleep disorders Allergy and immunity
Gastrointestinal Allergic rhinitis
Pancreatitis Rheumatoid arthritis
Intestinal disorders Hematological and oncological
Liver disease† cancer
Esophageal disorder Neurological
Hepatitis Epilepsy
Genitourinary and reproductive Parkinson’s disease
Female genitourinary disorders Other
Polycystic ovarian syndrome Degenerative eye disorder
Allergy and immunity Skin ulcer
HIV
Lupus
Tuberculosis
Hematological and oncological
Anemia
Sickle cell anemia
Neurological
Migraines
Dementia
Paralysis
Multiple sclerosis
Other
Non-cardiac congenital disorder
Sarcoidosis
Amyloidosis
Cystic fibrosis
*Non-thrombotic, non-athlerosclerotic.
‡Excluding chronic hepatitis.
COPD, chronic obstructive pulmonary disease.
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be less likely to support HbA1c control.11 These results
may be at least partially explained by HbA1c control
being prioritized over other care in diabetes, especially
by patients,26 as glycemic control has long been the
major focus on diabetes care.
All conditions that were related to any lack of achieve-
ment of testing goals were related to not achieving the
LDL testing goal. One possible explanation for the lack
of LDL testing with many of these conditions is the
potential lack of provider cuing to order the test when
LDL testing is not a shared care goal between diabetes
and the comorbidity.11 We have seen in prior work that
patients with diabetes and conditions that share cardio-
vascular care, such as hyperlipidemia, are more likely to
have LDL testing performed than patients who do not
have conditions that share diabetes care.12 Another pos-
sible explanation is that the LDL test is more challen-
ging for patients to complete, compared to the HbA1c
or kidney test, as it requires fasting and often a return
visit. There were no conditions associated with not
achieving HbA1c or kidney testing, both tests that can
be performed without fasting. Past work showed patients
prioritize diabetes care less than other healthcare when
they had non-diabetes-related competing health pro-
blems.13 It could be that patients do not prioritize an
inconvenient test when they have other competing
demands that do not share the LDL testing goal.11–13
Over half of the conditions studied had no relation-
ship to any testing or control goals. Among these condi-
tions are many that share diabetes care goals (eg,
peripheral atherosclerosis) and could be expected to
support goal achievement.11 Many were conditions that
can be symptomatic (eg, back problems) or severe (eg,
stroke), and therefore could distract from diabetes
care.11 This finding suggests that overlap of goals with
diabetes care, or potential for symptoms, is alone insuffi-
cient to determine if a comorbid condition will be
related to achievement or lack of achievement of dia-
betes care goals. Other factors, such as preference for
care, patient context, and health system characteristics,
play a role and must be considered in multimorbidity
care.5 32
Strengths and limitations
The major strengths of this study are the inclusion of a
comprehensive set of 62 chronic conditions, six diabetes
care goals, and a large sample across multiple health
systems. It is important to acknowledge that the sample
is from one Midwest state and only includes health
systems that participate in public reporting and that this
may limit generalizability. However, patients come from
a wide range of ages, race/ethnicities and payors, we
were able to adjust for multiple patient characteristics,
the health systems did not all share any common care
approaches or characteristics, and diabetes care goal
achievement was similar to results from a national
sample in 2011.33 While we included several sociodemo-
graphic variables, we recognize that in our study, as in
any similar analysis, there were unmeasured patient
characteristics for which we could not make adjustments.
To establish actively managed comorbid conditions, we
used ICD-9 codes billed at face-to-face visits in the base-
line year, as has been performed previously.20 21 There is
a risk for underdiagnosis of certain conditions with this
approach, such as obesity34 and depression;35 however,
there is less risk of bias than with condition patient self-
report.21 There is also a potential for patients to receive
some care and achieve diabetes care goals outside of
their medical home health system, and this goal achieve-
ment would not be recognized in our analysis. Our statis-
tical approach included multiple variables, and many
conditions were of low prevalence. We chose not to
correct for multiple comparisons, such as with the
Bonferroni method, to avoid increasing type 2 error in
this first-step study. Instead, we used a p value <0.01 to
determine significant associations. We do note that the
impact of some conditions on care goal achievement are
small in magnitude while statistically significant (ie, OR
1.1) and their clinical significance therefore could be
limited and should be tested in other populations in
future work. There is also a potential for interaction
effects among conditions, but these were not studied in
the current analyses and the impact of combinations of
conditions should be studied in future work. Finally, we
used publicly reported testing and control care goals as
markers of diabetes quality, as these are relevant to our
population of patients with diabetes, consistently meas-
urable, and there is agreement that achieving these
goals leads to better long-term outcomes.7 31 It is
important to note that there are other aspects of care,
other health outcomes and patient factors that were not
tested in this study as the study was not designed to
address them, including patient preference for care,
patient contextual factors and provider and health
system priorities for care.5 11 13 32 We also recognize that
some of our findings could be due to chance. Future
work should assess broader, more patient-oriented long-
term outcomes, such as health-related quality of life and
mortality and include more patient sociodemographic
and context measures.
Implications
Our findings on the relationship between individual
chronic conditions and diabetes care goal achievement
have several implications for the design of future multi-
morbidity interventions if borne out in future research.
It is well established that there is a potential to improve
control through better self-care and better testing. The
importance of BP and LDL control alongside HbA1c
control could be emphasized in patient education. Our
results support targeted lifestyle interventions for
patients with diabetes and co-occurring conditions that
are associated with lack of care goal achievement of
more than one goal, such as CHF or obesity.
Patient-centered medical home elements, such as regis-
tries and group visits,36 could target patients with
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diabetes and specific comorbidities to provide support-
ive, integrated diabetes and comorbidity care.26 37 This
may also help patients and providers prioritize diabetes
care goals, such as when achieving a care goal can
benefit multiple conditions32 and to maximize benefits
while decreasing harms, especially among patients in
whom it might not be appropriate to achieve all diabetes
care goals.7 38 Additional previsit planning to ensure
fasting laboratory completion,36 or non-fasting lipid tests
could be used to increase cholesterol testing.39 Finally,
given that over half of the tested conditions had no rela-
tionship with diabetes care, these conditions could be
de-emphasized in certain situations in order to create a
more manageable list of conditions for which care could
be integrated.40
Diabetes rarely occurs outside the setting of multimor-
bidity, multimorbidity complicates diabetes care and
interventions are urgently needed to effectively manage
these complex patients. Our study shows which condi-
tions are associated with achieving specific diabetes care
goals. If these results are borne out in further studies in
different populations, future interventions could target
patients at risk for not achieving specific diabetes care
goals based on their individual comorbidities.
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